KHONDRION Employee Directory

Biotechnology ResearchGelderland, Netherlands11-50 Employees

Khondrion is a clinical-stage biotechnology company focused on discovering and developing therapies for primary mitochondrial diseases. Its lead asset, sonlicromanol, is advancing in late-stage development as a potential first-in-class oral treatment for a range of inherited mitochondrial disorders, with regulatory designations that recognize its potential impact. The company operates from Nijmegen, Netherlands, and collaborates with patient organizations and a global network of clinical and academic partners to accelerate discovery and development. Its in-house program portfolio includes small molecules and associated biomarker and diagnostic research, aiming to deliver transformative medicines for patients with mitochondrial disease. Founded by Professor Jan Smeitink, Khondrion emphasizes building a wholly-owned pipeline and advancing discovery programs within the broader field of mitochondrial medicine.

Sign up for free to view info

Company overview Email format